45
Views
9
CrossRef citations to date
0
Altmetric
Original Investigations

Movement sequencing abilities and basal ganglia morphology in first-episode schizophrenia

, PhD , MD, , , , , & show all
Pages 752-762 | Received 27 Feb 2007, Published online: 08 Dec 2009

References

  • Bachmann S, Bottmer C, Shroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 2005; 162: 2337–2343
  • Bartlett EJ, Brodie JD, Simkowitz P, et al. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry 1994; 151: 681–686
  • Benes FM, Pakevich PA, Davidson J, Domesick VB. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 1985; 329: 265–273
  • Biver F, Goldman S, Luxen A, et al. Altered frontostriatal relationship in unmedicated schizophrenic patients. Psychiatry Res 1995; 61: 161–171
  • Blackwood DH, Young AH, McQueen JK, et al. Magnetic resonance imaging in schizophrenia: altered brain morphology associated with P300 abnormalities and eye tracking dysfunction. Biol Psychiatry 1991; 30: 753–769
  • Bogerts B, Meertz E, Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 1985; 42: 784–791
  • Bombin I, Arango C, Buchanan RW. Significance and meaning of neurological soft signs in schizophrenia: two decades later. Schizophr Bull 2005; 31: 962–977
  • Bottmer C, Bachmann S, Pantel J, et al. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res 2005; 140: 239–250
  • Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992; 49: 921–926
  • Brett M, Anton JL, Valabregue R, Poline JB. Region of interest analysis using an SPM toolbox. Neuroimage 2002; 16(2)497
  • Brown KW, Wardlaw JM, White T, Wlaker N. Caudate nucleus area in drug-induced parkinsonism. Acta Psychiatr Scand 1996; 94: 348–351
  • Buchanan RW, Heinrichs RW. The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989; 27: 335–350
  • Buchanan RW, Breier A, Kirkpatrick B, et al. Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993; 150: 59–65
  • Buchsbaum MS, Hazlett EA. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 1998; 24: 343–364
  • Buchsbaum MS, Haier RJ, Potkin SG, et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 1992; 49: 935–942
  • Buchsbaum MS, Shihabuddin L, Brickman AM, et al. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res 2003; 64: 53–62
  • Ceskova E, Prikryl R, Kasparek T. Neurological soft signs and their relationship to outcome in first-episode schizophrenia. Int J Neuropsychopharmacol 2006; 9(Suppl 1)S17
  • Chakos MH, Lieberman JA, Bilder RM, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430–1436
  • Chakos MH, Lieberman JA, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine (Letter). Lancet 1995; 345: 456–457
  • Chakos MH, Shirakawa O, Lieberman J, Lee H, Bilder R, Tamminga CA. Striatal enlargement in rats chronically treated with neuroleptic. Biol Psychiatry 1998; 44: 675–684
  • Correy-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry 1995; 152: 447–449
  • Corson PW, Nopoulos P, Miller DD, Arndt S, Andreasen NC. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 1999a; 156: 1200–1204
  • Corson PW, Nopoulos P, Andreasen NC, Heckel D, Arndt S. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol Psychiatry 1999b; 46: 712–720
  • Crider A. Perseveration in schizophrenia. Schizophr Bull 1997; 23: 63–74
  • Dalgalarrondo P, Gattaz WF. Basal ganglia abnormalities in tardive dyskinesia: possible relationship with duration of neuroleptic treatment. Eur Arch Psychiatry Clin Neurosci 1994; 244: 272–277
  • Dazzan P, Murray RM. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry 2002; 181(Suppl 43)S50–57
  • Dazzan P, Morgan KD, Orr KG, et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 2004; 127: 143–153
  • Delevoye-Turrell Y, Giersch A, Danion JM. Abnormal sequencing of motor actions in patients with schizophrenia: evidence from grip force adjustments during object manipulation. Am J Psychiatry 2003; 160: 134–141
  • DeLisi LE, Hoff AL, Schwartz JE, et al. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry 1991; 29: 159–175
  • Elkashef AM, Buchanan RW, Gellad F, Munson RC, Breier A. Basal ganglia pathology in schizophrenia and tardive dyskinesia: An MRI quantitative study. Am J Psychiatry 1994; 151: 752–755
  • Flaum M, Swayze VW II, O′Leary DS, et al. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am J Psychiatry 1995; 152: 704–714
  • Frazier JA, Giedd JN, Hamburger SD, et al. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry 1996a; 53: 614–624
  • Frazier JA, Giedd JN, Kaysen D, et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 1996b; 153: 564–566
  • Gordon CT, Frazier JA, McKenna K, et al. Childhood-onset schizophrenia: an NIMH study in progress. Schizophr Bull 1994; 20: 697–712
  • Graybiel AM. The basal ganglia and cognitive pattern generators. Schizophr Bull 1997; 23: 459–469
  • Gunduz H, Wu H, Ashtari M, et al. Basal ganglia volume in first-episode schizophrenia and healthy comparison subjects. Biol Psychiatry 2002; 51: 801–808
  • Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998; 155: 1711–1717
  • Hazeltine E, Grafton ST, Ivry R. Attention and stimulus characteristics determine the locus of motor-sequence encoding. Brain 1997; 120: 123–140
  • Heckers S, Heinsen H, Heinsen Y, Beckmann H. Cortex, white matter, and basal ganglia in schizophrenia: a volumetric post-mortem study. Biol Psychiatry 1991; 29: 556–566
  • Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 1988; 145: 11–18
  • Hokama H, Shenton ME, Nestor PG, et al. Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Res 1995; 61: 209–229
  • Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 1996; 153: 41–49
  • Holt DJ, Herman MM, Hyde TM, et al. Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience 1999; 94: 21–31
  • Jernigan TL, Zisook S, Heaton RK, Moranville JT. Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry 1991; 48: 881–890
  • Kelsoe JR, Jr, Cadet JL, Pickar D, Weinberger DR. Quantitative neuroanatomy in schizophrenia: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1988; 45: 533–541
  • Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol 1992; 15: 488–500
  • Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment (letter). Lancet 1994; 344: 1434
  • Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 1998; 155: 774–778
  • Keshavan MS, Sandres RD, Sweeney JA, et al. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 2003; 160: 1298–1304
  • Klintzova AJ, Haselhorst NA, Ranova NA, Schenk H, Istomin VV. The effects of haloperidol on synaptic plasticity in rat′s medial prefrontal cortex. J Hirnforsch 1989; 1: 51–57
  • Lang DJ, Kopala LC, Vandorpe RA, et al. An MRI study of basal ganglia volumes in first episode schizophrenia patients treated with risperidone. Am J Psychiatry 2001; 158: 625–631
  • Lang DJ, Kopala LC, Vandorpe RA, et al. Reduced basal ganglia volumes after swithching to olanzapine in chronically treated patients with schizophrenia. Am J Psychiatry 2004; 161: 1829–1836
  • Lanser MG, Berger HJ, Ellenbroek BA, Cools AR, Zitman FG. Perseveration in schizophrenia: failure to generate a plan and relationship with the psychomotor poverty subsyndrome. Psychiatry Res 2002; 112: 13–26
  • Lehericy S, Bardinet E, Tremblay L, et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cerebral Cortex 2006; 16: 149–161
  • Levitt JJ, McCarley RW, Dickey CC, et al. MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. Am J Psychiatry 2002; 159: 1190–1197
  • Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916–928
  • Levy R, Czernecki V. Apathy and the basal ganglia. J Neurol 2006; 253(Suppl 7)54–61
  • Massana G, Salgado-Pineda P, Junque C, et al. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J Clin Psychopharmacol 2005; 25: 111–117
  • Menon V, Anagnoson RT, Glover GH, Pfefferbaum A. Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am J Psychiatry 2001; 158: 646–649
  • Meshul CK, Casey DE. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res 1989; 489: 338–346
  • Milon CC, Andreasen NC, Ardnt S, Swayze VW II, Cohen GA. MRI abnormalities in tardive dyskinesia. Psychiatry Res 1991; 40: 157–166
  • Prikryl R, Ceskova E, Kasparek T, Kucerova H. Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. J Psy Res 2006; 40: 141–146
  • Rajarethinam RP, Keshavan MS, Vemulapalli M, Keshavan MS. Reduction of left caudate volume in offspring of patients with schizophrenia. Clin EEG Neurosci 2004; 35: 4
  • Ridley RM. The psychology of perseverative and stereotyped behaviour. Prog Neurobiol 1994; 44: 221–231
  • Roberts RC, Conley R, Kung L, Peretti FJ, Chute DJ. Reduced striatal spine size in schizophrenia: a postmortem ultrastructural study. NeuroReport 1996; 7: 1214–1218
  • Rubin P, Vorstrup S, Hemmingsen R, et al. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatr Scand 1994; 90: 385–390
  • Scheepers FE, de Wied CC, Hulshoff Pol HE, van de Flier W, van der Linden JA, Kahn RS. The effects of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology 2001a; 24: 47–54
  • Scheepers FE, de Wied CC, Hulshoff Pol HE, Kahn R. Effect of clozapine on caudate nucleus volume in relation to symptoms in schizophrenia. Am J Psychiatry 2001b; 158: 644–646
  • Stratta P, Mancini F, Mattei P, Daneluzzo E, Casacchia M, Rossi A. Asssociation between striatal reduction and poor Wisconsin Card Sorting Test performance in patients with schizophrenia. Biol Psychiatry 1997; 42: 816–820
  • Swayze VW II, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC. Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992; 31: 221–240
  • Takase K, Tamagaki C, Okugawa G, et al. Reduced white matter volume of the caudate neucleus in patients with schizophrenia. Neuropsychobiology 2004; 50: 296–300
  • Tanji J. Sequential organization of multiple movements: involvement of cortical motor areas. Annu Rev Neurosci 2001; 24: 631–651
  • Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labelling of activations in spm using a macroscopic anatomical parcellation of the MNI MRI single subject brain. Neuroimage 2002; 15: 273–289
  • Uranova NA, Orlovskaya DD, Apel K, Klintsova AJ, Haselhorst U, Schenk H. Morphometric study of synaptic patterns in the rat caudate neucleus and hippocampus under haloperidol treatment. Synapse 1991; 7: 253–259
  • Wolkin A, Jaeger J, Brodie JD, et al. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 1985; 142: 564–571
  • Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64: 663–667
  • Young AH, Blackwood DH, Roxborough H, McQueen JK, Martin MJ, Kean D. A magnetic resonance imaging study of schizophrenia: brain structure and clinical symptoms. Br J Psychiatry 1991; 158: 158–164

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.